Aug 08, 2023
51:50
For every 50 shares held, investors received 51.
The split itself did not change the total investment value.
Genomics BioSci & Tech. Co., Ltd. (TWSE:4195) operates in the Biotechnology industry.
Genomics BioSci & Tech. Co., Ltd. company overviewGenomics BioSci & Tech. Co., Ltd.'s most recent stock split was on August 8, 2023. It was a 51-for-50 forward split, so shareholders received 51 shares for every 50 they held.
Genomics BioSci & Tech. Co., Ltd. (TWSE:4195) has split its stock 2 times: a 51-for-50 split on August 26, 2022 and a 51-for-50 split on August 8, 2023.
Genomics BioSci & Tech. Co., Ltd. has split its stock 2 times. This history records 2 forward splits between August 26, 2022 and August 8, 2023.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Genomics BioSci & Tech. Co., Ltd.'s 51-for-50 split on August 8, 2023, every 50 shares became 51 shares.
Genomics BioSci & Tech. Co., Ltd. has not announced a new split in our records. Its most recent split was on August 8, 2023, 3 years ago. Companies announce splits in advance, and any new TWSE:4195 split will appear on this page.
Already premium?